Reuters logo
BRIEF-Immune Pharmaceuticals appoints Daniel Teper as CEO for Cytovia
August 28, 2017 / 12:45 PM / 24 days ago

BRIEF-Immune Pharmaceuticals appoints Daniel Teper as CEO for Cytovia

Aug 28 (Reuters) - Immune Pharmaceuticals:

* Immune Pharmaceuticals provides research and development and business update and summary of recent financial highlights.

* Daniel Teper was named Chief Executive Officer of Cytovia.

* Rama Rao, a former Novartis executive, was appointed as Cytovia’s interim CFO and COO. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below